GlassScriptPhysician profile
Thomas G Serio
NPI 1184654055
$3,654.74
in general payments reported to CMS, 2019-2025
35 companies · $415 in 2025
The $415 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $562 · 2020: $533 · 2021: $568 · 2022: $603 · 2023: $593 · 2024: $380 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,388.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $412.66 | 2019-2023 | Xtampza |
| Pfizer INC. | $397.80 | 2019-2025 | |
| Scilex Pharmaceuticals INC. | $301.58 | 2022-2025 | Ztlido |
| Indivior INC. | $247.55 | 2019-2023 | Sublocade |
| Abbvie INC. | $196.19 | 2019-2024 | Synthroid |
| Lilly USA, LLC | $194.42 | 2020-2025 | Mounjaro, Kisunla, Zepbound |
| Amgen INC. | $178.97 | 2019-2024 | Otezla, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $178.11 | 2019-2025 | Trulance, Xifaxan, Relistor |
| Novo Nordisk INC | $156.36 | 2020-2025 | Ozempic, Rybelsus |
| Ibsa Pharma INC. | $154.52 | 2023-2025 | Tirosint, Licart, Tirosint |
| Kowa Pharmaceuticals America, INC. | $122.37 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $103.78 | 2021-2022 | |
| Almatica Pharma LLC | $95.11 | 2021-2025 | Teriparatide |
| Horizon Therapeutics Plc | $84.68 | 2019 | |
| Axsome Therapeutics, INC. | $79.05 | 2023-2025 | Sunosi |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $74.78 | 2019 | |
| Eisai INC. | $69.92 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $67.74 | 2020-2023 | Breztri |
| Sanofi-Aventis U.S. LLC | $63.68 | 2019 | |
| Ironshore Pharmaceuticals INC. | $51.02 | 2020-2022 | |
| Exact Sciences Corporation | $49.96 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $49.56 | 2022-2023 | Belsomra |
| Corcept Therapeutics | $47.29 | 2023 | Korlym |
| Takeda Pharmaceuticals U.S.A., INC. | $43.67 | 2019-2021 | |
| Avanir Pharmaceuticals, INC. | $39.53 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.80 | 2022 | |
| Lundbeck LLC | $23.46 | 2025 | Rexulti |
| Astellas Pharma US INC | $23.21 | 2023 | Myrbetriq |
| Phathom Pharmaceuticals, INC. | $20.12 | 2025 | Voquezna |
| Janssen Pharmaceuticals, INC | $19.35 | 2023 | Xarelto |
| Pacira Therapeutics, INC. | $19.25 | 2019 | |
| Seqirus USA INC | $16.34 | 2019 | |
| Alkermes, INC. | $14.63 | 2019 | |
| Allergan, INC. | $13.75 | 2020 | |
| Amarin Pharma, INC. | $12.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Serio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.